By Monica Heger This story was originally published Jan. 9.
Knome has hired a new CEO as part of its strategy to expand its whole-genome sequence interpretation services into the clinic.
By Uduak Grace Thomas
As genome sequencing continues to makes inroads into clinics, established vendors and small startups are honing their informatics portfolios to tap into the growing market for software in this setting.
Martin Madaus has been named Quanterix's permanent CEO. Madaus, who is chairman of the company, had been serving as interim CEO since May when David Okrongly left the Cambridge, Mass.-based company.
Andrew Feinberg, director of the Center for Epigenetics at the Institute for Basic Biomedical Research at Johns Hopkins University School of Medicine, has been awarded a Director's Pioneer Award by the National Institutes of Health.
Martin Madaus has been named as Quanterix's permanent CEO. Madaus, who is chairman of the company, had been serving as interim CEO since May when David Okrongly left the Cambridge, Mass.-based array company.
The former commissioner of the FDA has returned to the venture capital firm New Enterprise Associates as a special partner on the healthcare investment team.
Emory University has found that two of its researchers failed to divulge they had received funds from China, according to the Atlanta Journal-Constitution.
